Work for Monopar Therapeutics Inc.?

Claim Your Profile

Monopar Therapeutics Inc. Logo Image

Monopar Therapeutics Inc.

Monopar Therapeutics Inc. Banner Image

About Monopar Therapeutics Inc.

1-10 Employees
Based in Wilmette, Illinois

Monopar Therapeutics is a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. Monopar's pipeline consists of Validive® for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients; camsirubicin for the treatment of advanced soft tissue sarcoma; and a late-stage preclinical antibody, MNPR-101, for advanced cancers and severe COVID-19.

Ticker:
MNPR
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol